Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR)
Historical Holders from Q4 2024 to Q3 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Symbol
-
CTXR on Nasdaq
-
Shares outstanding
-
16,724,051
-
Price per share
-
$1.16
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
624,408
-
Total reported value
-
$773,221
-
% of total 13F portfolios
-
0%
-
Share change
-
-464,256
-
Value change
-
-$686,704
-
Number of holders
-
34
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
CVI Investments, Inc.
|
9.9%
|
|
$2,048,905
|
|
1,655,681
|
|
CVI Investments, Inc.
|
20 Oct 2025
|
As of 30 Sep 2025,
Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) has
34
institutional shareholders
filing 13F forms.
They hold
624,408 shares.
of 16,724,051
outstanding shares (3.7%)
.
Institutional Holders of Citius Pharmaceuticals, Inc. - Common Stock, $0.001 par value per share (CTXR) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q3
|
624,408
|
$773,221
|
-$686,704
|
$13,516
|
$142,724
|
$1.24
|
34
|
|
2025 Q2
|
928,766
|
$1,477,067
|
+$473,601
|
$70,119
|
$78,069
|
$1.59
|
31
|
|
2025 Q1
|
635,473
|
$947,155
|
-$78,728
|
$14,602
|
$27,982
|
$1.49
|
27
|
|
2024 Q4
|
604,707
|
$2,418,021
|
+$2,406,413
|
$102,560
|
$243,584
|
$4.00
|
28
|